Zurn Elkay (ZWS) director reports 590-share acquisition at $46.67
Zurn Elkay Water Solutions (ZWS) disclosed a director equity transaction.
Rhea-AI Filing Summary
Zurn Elkay Water Solutions (ZWS) disclosed a director equity transaction. On 10/15/2025, Director David C. Longren acquired 590 shares of common stock at $46.67, bringing his directly held stake to 94,128 shares. The award reflects payment of director fees in restricted stock units that vested immediately and will be settled six months after his service as a director ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 590 | $46.67 | $28K |
Footnotes (1)
- F1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ZWS report on Form 4?
A director acquisition of 590 common shares at $46.67 on 10/15/2025, with post-transaction holdings of 94,128 shares (direct).
Who is the reporting person in ZWS’s Form 4?
David C. Longren, serving as a Director.
What is the director’s beneficial ownership after the transaction?
94,128 shares, held directly.
What is the nature of the equity award noted?
Director fees paid in RSUs that vested immediately and are payable six months after the director’s service ends.
Was this filed by one reporting person?
Yes. The filing is by one reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.